ChipCare is a Toronto based pre-revenue company developing a highly versatile point-of-care (POC) diagnostics platform which will enable an unparalleled sample-to-action workflow in the clinic. Our polyvalent analyzer (PAx) utilizes a patented approach to analyte detection that can perform multiple key assay classes including cell surface markers, proteins and nucleic acids. Our multiplexing technology allows for the simultaneous detection and discrimination of multiple diseases in a single patient test. The incorporation of resistance markers in the test enables clinicians to prescribe the most appropriate treatment and support antibiotic stewardship. ChipCare’s patented detection technology enables healthcare professionals to provide an accurate, actionable differential diagnosis for effective and timely treatment. ChipCare's initial focus is on the sexually transmitted infections (STI) market in North America and Europe, enabling Physicians to provide true test and treat options for their patients, significantly enhancing the overall quality of patient care.Inaccurate data? Flag it here.